Skip to main content

Advertisement

SpringerLink
Log in

Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point”

  • Invited Commentary
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

The Original Article was published on 06 December 2009

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Botteri E, Sandri MT, Bagnardi V, Munzone E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A, Curigliano G, Salvatici M, Verri E, Adamoli L,Goldhirsch A, Nolè F (2010) Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat (epub)

  2. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LW (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2:4218–4224

    Article  Google Scholar 

  3. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781–791

    Article  CAS  PubMed  Google Scholar 

  4. Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25:127–141

    Article  PubMed  Google Scholar 

  5. Tibbe AG, Miller MC, Terstappen LW (2007) Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71:154–162

    PubMed  Google Scholar 

  6. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. British Med J 339:157–160

    Google Scholar 

  7. Royston P, Sauerbrei W (2008) Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Wiley, Chichester

    Google Scholar 

  8. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics (2006) Reporting recommendations for tumor marker prognostic studies (REMARK). Breast Cancer Res Treat 100: 229–35

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gyn./OB, University of Tübingen, Calwer Str. 7, 72076, Tübingen, Germany

    T. Fehm

  2. Institute of Medical Biometry and Informatics, University Medical Center Freiburg, 79104, Freiburg, Germany

    W. Sauerbrei

Authors
  1. T. Fehm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Sauerbrei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Fehm.

Additional information

This is an invited commentary to article doi: 10.1007/s10549-009-0668-7

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fehm, T., Sauerbrei, W. Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point”. Breast Cancer Res Treat 122, 219–220 (2010). https://doi.org/10.1007/s10549-010-0762-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0762-x

Keywords

Search

Navigation